234 related articles for article (PubMed ID: 11804028)
1. Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene.
Odgren PR; Kim N; van Wesenbeeck L; MacKay C; Mason-Savas A; Safadi FF; Popoff SN; Lengner C; van-Hul W; Choi Y; Marks SC
Int J Dev Biol; 2001 Dec; 45(8):853-9. PubMed ID: 11804028
[TBL] [Abstract][Full Text] [Related]
2. The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue.
Odgren PR; Kim N; MacKay CA; Mason-Savas A; Choi Y; Marks SC
Connect Tissue Res; 2003; 44 Suppl 1():264-71. PubMed ID: 12952207
[TBL] [Abstract][Full Text] [Related]
3. Perspective. Osteoclastogenesis and growth plate chondrocyte differentiation: emergence of convergence.
Odgren PR; Philbrick WM; Gartland A
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):181-93. PubMed ID: 14696966
[TBL] [Abstract][Full Text] [Related]
4. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
5. Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
Kapur RP; Yao Z; Iida MH; Clarke CM; Doggett B; Xing L; Boyce BF
J Bone Miner Res; 2004 Oct; 19(10):1689-97. PubMed ID: 15355564
[TBL] [Abstract][Full Text] [Related]
6. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
Kong YY; Yoshida H; Sarosi I; Tan HL; Timms E; Capparelli C; Morony S; Oliveira-dos-Santos AJ; Van G; Itie A; Khoo W; Wakeham A; Dunstan CR; Lacey DL; Mak TW; Boyle WJ; Penninger JM
Nature; 1999 Jan; 397(6717):315-23. PubMed ID: 9950424
[TBL] [Abstract][Full Text] [Related]
7. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
Sordillo EM; Pearse RN
Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice.
Shalhoub V; Jackson ME; Paradise C; Stein GS; Lian JB; Marks SC
J Cell Physiol; 1996 Feb; 166(2):340-50. PubMed ID: 8591994
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the differentiation and function of osteoclasts.
Chambers TJ
J Pathol; 2000 Sep; 192(1):4-13. PubMed ID: 10951393
[TBL] [Abstract][Full Text] [Related]
10. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways.
Takami M; Cho ES; Lee SY; Kamijo R; Yim M
FEBS Lett; 2005 Jan; 579(3):832-8. PubMed ID: 15670856
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
[TBL] [Abstract][Full Text] [Related]
14. Colony-stimulating factor-1 (CSF-1) rescues osteoblast attachment, survival and sorting of beta-actin mRNA in the toothless (tl-osteopetrotic) mutation in the rat.
Watanabe H; MacKay CA; Mason-Savas A; Kislauskis EH; Marks SC
Int J Dev Biol; 2000 Feb; 44(2):201-7. PubMed ID: 10794078
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis.
Mizuno A; Kanno T; Hoshi M; Shibata O; Yano K; Fujise N; Kinosaki M; Yamaguchi K; Tsuda E; Murakami A; Yasuda H; Higashio K
J Bone Miner Metab; 2002; 20(6):337-44. PubMed ID: 12434161
[TBL] [Abstract][Full Text] [Related]
16. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
Kawaida R; Ohtsuka T; Okutsu J; Takahashi T; Kadono Y; Oda H; Hikita A; Nakamura K; Tanaka S; Furukawa H
J Exp Med; 2003 Apr; 197(8):1029-35. PubMed ID: 12707301
[TBL] [Abstract][Full Text] [Related]
17. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
Abu-Amer Y; Abbas S; Hirayama T
J Cell Biochem; 2004 Nov; 93(5):980-9. PubMed ID: 15389885
[TBL] [Abstract][Full Text] [Related]
18. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.
Kim N; Odgren PR; Kim DK; Marks SC; Choi Y
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10905-10. PubMed ID: 10984520
[TBL] [Abstract][Full Text] [Related]
19. Mutation of macrophage colony stimulating factor (Csf1) causes osteopetrosis in the tl rat.
Dobbins DE; Sood R; Hashiramoto A; Hansen CT; Wilder RL; Remmers EF
Biochem Biophys Res Commun; 2002 Jun; 294(5):1114-20. PubMed ID: 12074592
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
